Search company, investor...

Pathology

pathologyinc.com

Stage

Acquired | Acquired

About Pathology

Pathology, Inc. is one of the country's premier full-service independent Women's Health laboratory, providing expertise in reproductive FDA donor testing as well as anatomic, molecular and digital pathology services. The company's integrated diagnostic services help doctors personalize patient care to optimally treat disease and maintain health and wellness.

Headquarters Location

19951 Mariner Avenue Suite 150

Torrance, California, 90503,

United States

310-769-0561

Missing: Pathology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pathology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Pathology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pathology is included in 1 Expert Collection, including Women's Health & Wellness.

W

Women's Health & Wellness

1,493 items

Startups focused on providing products and services catering to women's health and wellbeing.

Pathology Patents

Pathology has filed 3 patents.

The 3 most popular patent topics include:

  • Bioinformatics
  • Business intelligence
  • Data management
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/28/2016

9/1/2020

Distributed computing architecture, Blood tests, Data management, Costs, Management accounting

Grant

Application Date

1/28/2016

Grant Date

9/1/2020

Title

Related Topics

Distributed computing architecture, Blood tests, Data management, Costs, Management accounting

Status

Grant

Latest Pathology News

Paige Publishes Data Supporting First FDA-Authorized AI Software for Digital Pathology

Dec 22, 2022

Share Pathologists using Paige Prostate Detect had 70% reduction in false negative diagnoses and 24% reduction in false positive diagnoses Results published in Archives of Pathology & Laboratory Medicine served as foundation of first FDA authorized AI software in digital pathology Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications,announced it has published the results of a pivotal study demonstrating accuracy gains in pathologists’ diagnosis of prostate cancer when using Paige Prostate Detect, an FDA-authorized AI software that assists pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies. “The study provides an important validation of our underlying technology and of the first-ever AI software for digital pathology to be authorized by the FDA” The study was designed to compare the diagnostic accuracy of pathologists reviewing images of prostate biopsies for the presence of prostate cancer with and without the assistance of Paige Prostate Detect. In the study, pathologists were shown to increase approximately eight percentage points in sensitivity in correctly diagnosing cancer (from 88.7% to 96.6%) with an increase in specificity as well (from 97.3% to 98%). This represents a 70% reduction in false negative diagnoses and a 24% reduction in false positive diagnoses. Both non-specialist pathologists and specialist pathologists saw statistically significant sensitivity gains, with non-specialist pathologists showing a sensitivity of detection with assistance of Paige Prostate Detect similar to that of specialist pathologists. There was no statistical significance between improvements of pathologists who reviewed slides on-site or remotely, and there were no significant differences in performance across patient age, race and ethnicity. “These findings show Paige Prostate Detect is a robust AI software that can be used broadly in clinical practice to provide information physicians need to guide the accurate diagnosis of prostate cancer,” said David Klimstra, M.D., Founder and Chief Medical Officer at Paige. “While specialist pathologists are critical, they may not be available at every hospital and laboratory. By providing non-specialist pathologists with Paige Prostate Detect, we are able to give them a user-friendly tool that serves as a second pair of eyes to improve confidence in the diagnostic process. In turn, this heralds a revolution in how pathology is practiced and reinforces the central role pathologists play in patient care.” Paige Prostate Detect was tested on a wide range of tissue samples to simulate the cases pathologists often encounter in routine clinical practice. The dataset included 610 de-identified prostate needle biopsy whole slide images stained with H&E from 218 different institutions worldwide. Additionally, the data included a mix of hard and easy cases and was enriched with small tumor foci to challenge the system with lesions that can be overlooked by pathologists. “The study provides an important validation of our underlying technology and of the first-ever AI software for digital pathology to be authorized by the FDA,” said Thomas Fuchs, Dr.Sc., Founder and Chief Scientist at Paige. “Paige Prostate Detect demonstrated robust performance on a challenging dataset. Furthermore, our analysis suggests there is no unknown bias in how Paige Prostate Detect works, a critical step in ensuring that such tools do not contribute to health care disparities. Together with other studies on Paige’s technology, this study again demonstrates that Paige Prostate Detect is generalizable to multiple laboratories around the world.”

Pathology Frequently Asked Questions (FAQ)

  • Where is Pathology's headquarters?

    Pathology's headquarters is located at 19951 Mariner Avenue, Torrance.

  • What is Pathology's latest funding round?

    Pathology's latest funding round is Acquired.

  • Who are the investors of Pathology?

    Investors of Pathology include LabCorp, ABS Capital Partners and ORIX Growth Capital.

  • Who are Pathology's competitors?

    Competitors of Pathology include YouMail, BMI Healthcare, Ardent Health Services, Radisphere National Radiology Group, American Pathology Partners and 11 more.

Compare Pathology to Competitors

A
Ardent Health Services

Ardent Health Services, previously known as Behavioral Healthcare, invests in people, technology, facilities, and communities, producing high-quality care and extraordinary results. Ardent currently operates three health systems with a range of hospitals and employs multi-specialty physicians in multiple clinic locations across New Mexico, Oklahoma, and Texas. The company was founded in 1993 and is based in Nashville, Tennessee.

ExamWorks Logo
ExamWorks

ExamWorks is a provider of independent medical examinations, peer reviews, bill reviews and IME-related services to the insurance and legal industries, third-party administrators, self-insured parties and federal and state agencies. ExamWorks is dedicated to the national presence required to serve clients and the preservation of the local offices where clients receive exceptional service from credentialed physicians and other medical providers.

L
LifeStar Cos.

LifeStar Cos. aims to provide specialized transportation, language, and coordination services for the health care industry through three divisions: LifeStar Response is a network of locally and regionally branded emergency and non-emergency medical transport services. Care Ambulance is a provider of emergency and non-emergency medical transportation serving the Southeast. Access OnTime aims to provide comprehensive coordination of medical transportation and language services, doing work in workers' compensation.

B
Babybond Ultrasound

Rutland-based Babybond aims to provide private ultrasound scans and related services to pregnant woman from its wholly-owned and franchised centres across the UK. Founded by ultrasound professionals Jan and Mike Steward, the company has quickly established itself as the UK's leading national provider of such services and was a ISO Quality Endorsed ultrasound provider in the UK.

Paradigm Logo
Paradigm

Paradigm provides acute and ongoing catastrophic and complex case management services for traumatic brain injuries, spinal cord injuries, amputations, burns, wounds, and chronic pain. The company is a provider of complex and catastrophic medical management in the workers' compensation industry.

A
American Pathology Partners

American Pathology Partners is a network of pathology laboratories and practices dedicated to local and regional healthcare. Based on the individual needs of partner practices and laboratories, the company offers a wide array of world-class support services, including business support, access capital for liquidity and/or growth, and selected esoteric or subspecialty pathology services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.